- Home
- LOCO vs BNTC Comparison
LOCO vs BNTC Comparison
Compare LOCO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOCO | BNTC |
|---|---|---|
| Founded | 1980 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.2M | 451.0M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | LOCO | BNTC |
|---|---|---|
| Price | $11.65 | $12.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $18.00 | ★ $28.25 |
| AVG Volume (30 Days) | 226.3K | ★ 229.1K |
| Earning Date | 10-30-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.62 | N/A |
| EPS | ★ 0.89 | N/A |
| Revenue | ★ $480,815,000.00 | N/A |
| Revenue This Year | $5.67 | N/A |
| Revenue Next Year | $1.64 | N/A |
| P/E Ratio | $13.07 | ★ N/A |
| Revenue Growth | ★ 2.09 | N/A |
| 52 Week Low | $8.29 | $9.70 |
| 52 Week High | $13.14 | $17.15 |
Technical Indicators
Market Signals| Indicator | LOCO | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 70.75 | 38.63 |
| Support Level | $11.12 | $12.78 |
| Resistance Level | $11.40 | $13.68 |
| Average True Range (ATR) | 0.28 | 0.76 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 94.33 | 22.20 |
Price Performance
Historical ComparisonAbout LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.